$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
慢性丙型肝炎相关代谢疾病和心血管疾病
2025-10-19 11:44:20
Check Details
6-12岁儿童丙肝患者服用丙肝新药的相关研究
2025-10-19 11:44:20
Check Details
丙肝一小时即可诊断——采血即时检测
2025-10-19 11:44:20
Check Details
丙型肝炎肝硬化患者需定期监测肝癌
2025-10-19 11:44:20
Check Details
丙肝的3大并发症
2025-10-19 11:44:20
Check Details
与干扰素相比,接受DAA治丙肝降低多种癌症风险
2025-10-19 11:44:20
Check Details
丙肝治疗以抗病毒治疗为主
2025-10-19 11:44:20
Check Details
吉四代Vosevi和Mavyret上市封死了丙肝治疗的漏洞
2025-10-19 11:44:20
Check Details
丙肝患者治疗期间应如何做
2025-10-19 11:44:20
Check Details
新药治丙肝降低患者心血管疾病风险
2025-10-19 11:44:20
Check Details
慢性丙肝有什么危害?
2025-10-19 11:44:20
Check Details
吉三代治疗丙肝基因3型的疗效
2025-10-19 11:44:20
Check Details
1
2
...
5838
5839
5840
5841
5842
5843
5844
...
10242
10243
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Klygefa FDA Approval: Weekly Subcutaneous C5 Inhibition for AChR-Positive gMG
2
What Is Pralsetinib? RET-Positive Lung and Thyroid Cancer Explained
3
Sotorasib Diarrhea in NSCLC: Grading, Loperamide and Dose Adjustment
4
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
5
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
6
Pralsetinib and Hypertension in NSCLC: Risks, Monitoring and Management
7
Tucatinib Overview: HER2-Positive Breast Cancer and RAS Wild-Type Colorectal Cancer Dosing, Brain Metastases Data and Safety
8
FDA Approves Durvalumab Plus Enfortumab Vedotin for Perioperative Treatment of Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
9
Bepirovirsen (Hibsago) Prescribing Information: Indications, Boxed Warnings, Dose Adjustment and Monitoring
10
Avapritinib (Ayvakit) Prescribing Information: Indications, Dosage, Adverse Reactions and Safety Warnings
11
Daraxonrasib Pregnancy, Lactation and Contraception Safety
12
Afatinib Side Effects and Safety Management